Contrasting alloreactive CD4+ and CD8+ T cells: there's more to it than MHC restriction.
about
Therapeutics for Graft-versus-Host Disease: From Conventional Therapies to Novel Virotherapeutic StrategiesCurrent and future approaches for control of graft-versus-host disease.Intracellular MHC class II controls regulatory tolerance to allogeneic transplants.Burkitt lymphoma: pathogenesis and immune evasion.Complement regulates CD4 T-cell help to CD8 T cells required for murine allograft rejection.Pathophysiology of acute graft-versus-host disease: recent advances.Inhibition of histone methyltransferase EZH2 ameliorates early acute renal allograft rejection in ratsCytotoxic effector function of CD4-independent, CD8(+) T cells is mediated by TNF-α/TNFR.T-bet Promotes Acute Graft-versus-Host Disease by Regulating Recipient Hematopoietic Cells in Mice.Glucocorticoid-induced TNFR-related protein stimulation reverses cardiac allograft acceptance induced by CD40-CD40L blockade.CD8+ Th17 mediate costimulation blockade-resistant allograft rejection in T-bet-deficient miceImmunology of uterine transplantation: a review.Murine heterotopic heart transplant technique.Interferon gamma licensing of human dendritic cells in T-helper-independent CD8+ alloimmunity.Alloreactive T cells respond specifically to multiple distinct peptide-MHC complexes.Transforming growth factor-beta1 gene transfer is associated with the development of regulatory cells.
P2860
Q26751959-9FC05AAD-41F4-4759-BE45-E76B8F244850Q33642625-A3D8BB07-24D3-4A06-9D60-1DFBDCEB0CF9Q33896888-AE2C50E3-2127-4C17-A523-47B2FEA82DFBQ34189497-41EACD80-30E0-4D90-9216-6D35B2A6E3F7Q35167918-219AC15A-4E8D-4F92-9C2F-1A4760C2D541Q36156559-552A928A-EE3E-48D5-BD3B-E7A1C1888ED0Q36175311-11957CDD-E17B-4DDB-90AB-5659E3067FE5Q36468274-F610BA4F-09E1-4189-AEBE-117B6C1BA5E5Q36706319-0FB7D808-D5BC-4C47-BF3F-327041DB4392Q36838049-C91E5AA4-58AE-447B-A469-31C44B3AB792Q37259506-30CC5BAF-95B6-4A23-B646-AF13D2A6BF5DQ37964421-E23267C8-AC37-4E48-A2B9-EECAAEF6D333Q41858796-B7BC0F4D-5156-4C68-8AD5-ECFF4AD995BAQ41985455-1A9A57CC-BAE7-4B9C-A7B5-00C4B4436011Q42613015-777AE5D6-8F80-4E26-B573-9DB83BD9CACAQ43620835-3FD4AFF1-37B3-4B65-90E3-717EC051985C
P2860
Contrasting alloreactive CD4+ and CD8+ T cells: there's more to it than MHC restriction.
description
2003 nî lūn-bûn
@nan
2003 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2003 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
name
Contrasting alloreactive CD4+ and CD8+ T cells: there's more to it than MHC restriction.
@ast
Contrasting alloreactive CD4+ and CD8+ T cells: there's more to it than MHC restriction.
@en
type
label
Contrasting alloreactive CD4+ and CD8+ T cells: there's more to it than MHC restriction.
@ast
Contrasting alloreactive CD4+ and CD8+ T cells: there's more to it than MHC restriction.
@en
prefLabel
Contrasting alloreactive CD4+ and CD8+ T cells: there's more to it than MHC restriction.
@ast
Contrasting alloreactive CD4+ and CD8+ T cells: there's more to it than MHC restriction.
@en
P2860
P1476
Contrasting alloreactive CD4+ and CD8+ T cells: there's more to it than MHC restriction.
@en
P2093
D Keith Bishop
P2860
P304
P356
10.1034/J.1600-6143.2003.00036.X
P407
P577
2003-02-01T00:00:00Z